Detalhe da pesquisa
1.
T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals.
Cell
; 185(6): 1041-1051.e6, 2022 03 17.
Artigo
Inglês
| MEDLINE | ID: mdl-35202566
2.
Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses.
Cell
; 184(17): 4401-4413.e10, 2021 08 19.
Artigo
Inglês
| MEDLINE | ID: mdl-34265281
3.
T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals.
Cell
; 185(7): 1259, 2022 Mar 31.
Artigo
Inglês
| MEDLINE | ID: mdl-35364034
4.
Comparative Immunogenicity and Effectiveness of mRNA-1273, BNT162b2, and Ad26.COV2.S COVID-19 Vaccines.
J Infect Dis
; 225(7): 1141-1150, 2022 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34888672
5.
The Emerging Role for CTL Epitope Specificity in HIV Cure Efforts.
J Infect Dis
; 223(12 Suppl 2): 32-37, 2021 02 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33586771
6.
Polymorphic residues in HLA-B that mediate HIV control distinctly modulate peptide interactions with both TCR and KIR molecules.
Structure
; 2024 May 07.
Artigo
Inglês
| MEDLINE | ID: mdl-38733995
7.
A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta.
Front Immunol
; 14: 1135815, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36969239
8.
Viral and Host Mediators of Non-Suppressible HIV-1 Viremia.
medRxiv
; 2023 Mar 31.
Artigo
Inglês
| MEDLINE | ID: mdl-37034605
9.
Viral and host mediators of non-suppressible HIV-1 viremia.
Nat Med
; 29(12): 3212-3223, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37957382
10.
T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all prior infected and vaccinated individuals.
medRxiv
; 2022 Jan 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35018386
11.
HLA class-I-peptide stability mediates CD8+ T cell immunodominance hierarchies and facilitates HLA-associated immune control of HIV.
Cell Rep
; 36(2): 109378, 2021 07 13.
Artigo
Inglês
| MEDLINE | ID: mdl-34260940
12.
Comparative immunogenicity and effectiveness of mRNA-1273, BNT162b2 and Ad26.COV2.S COVID-19 vaccines.
medRxiv
; 2021 Oct 13.
Artigo
Inglês
| MEDLINE | ID: mdl-34671780